1	Human	human	_	_	_	_	_	_	_
2	MHC	MHC	_	_	_	_	_	_	_
3	class	class	_	_	_	_	_	_	_
4	II	ii	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	directed	direct	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	carboxyl	carboxyl	_	_	_	_	_	_	_
11	terminus	terminus	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	CIITA	CIITA	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	one	one	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	defective	defective	_	_	_	_	_	_	_
19	genes	gene	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	type	type	_	_	_	_	_	_	_
22	II	ii	_	_	_	_	_	_	_
23	MHC	MHC	_	_	_	_	_	_	_
24	combined	combined	_	_	_	_	_	_	_
25	immune	immune	_	_	_	_	_	_	_
26	deficiency	deficiency	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Type	type	_	_	_	_	_	_	_
2	II	ii	_	_	_	_	_	_	_
3	major	major	_	_	_	_	_	_	_
4	histocompatibility	histocompatibility	_	_	_	_	_	_	_
5	complex	complex	_	_	_	_	_	_	_
6	combined	combined	_	_	_	_	_	_	_
7	immune	immune	_	_	_	_	_	_	_
8	deficiency	deficiency	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	type	type	_	_	_	_	_	_	_
11	II	ii	_	_	_	_	_	_	_
12	MHC	MHC	_	_	_	_	_	_	_
13	CID	CID	_	_	_	_	_	_	_
14	or	or	_	_	_	_	_	_	_
15	bare	bare	_	_	_	_	_	_	_
16	lymphocyte	lymphocyte	_	_	_	_	_	_	_
17	syndrome	syndrome	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	congenital	congenital	_	_	_	_	_	_	_
22	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
23	disease	disease	_	_	_	_	_	_	_
24	characterized	characterize	_	_	_	_	_	_	_
25	by	by	_	_	_	_	_	_	_
26	absent	absent	_	_	_	_	_	_	_
27	MHC	MHC	_	_	_	_	_	_	_
28	class	class	_	_	_	_	_	_	_
29	II	ii	_	_	_	_	_	_	_
30	expression	expression	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	Four	four	_	_	_	_	_	_	_
2	distinct	distinct	_	_	_	_	_	_	_
3	complementation	complementation	_	_	_	_	_	_	_
4	groups	group	_	_	_	_	_	_	_
5	have	have	_	_	_	_	_	_	_
6	been	be	_	_	_	_	_	_	_
7	identified	identify	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	Recently	recently	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	defective	defective	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	group	group	_	_	_	_	_	_	_
8	II	ii	_	_	_	_	_	_	_
9	type	type	_	_	_	_	_	_	_
10	II	ii	_	_	_	_	_	_	_
11	MHC	MHC	_	_	_	_	_	_	_
12	CID	CID	_	_	_	_	_	_	_
13	has	have	_	_	_	_	_	_	_
14	been	be	_	_	_	_	_	_	_
15	isolated	isolate	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	termed	term	_	_	_	_	_	_	_
18	CIITA	CIITA	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	we	we	_	_	_	_	_	_	_
4	demonstrate	demonstrate	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	CIITA	CIITA	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	an	an	_	_	_	_	_	_	_
9	MHC	MHC	_	_	_	_	_	_	_
10	class	class	_	_	_	_	_	_	_
11	II	ii	_	_	_	_	_	_	_
12	gene-specific	gene-specific	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	activator	activator	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transcription	transcription	_	_	_	_	_	_	_
3	activation	activation	_	_	_	_	_	_	_
4	function	function	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	provided	provide	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	N-terminal	n-terminal	_	_	_	_	_	_	_
10	acidic	acidic	_	_	_	_	_	_	_
11	domain	domain	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	amino	amino	_	_	_	_	_	_	_
14	acids	acid	_	_	_	_	_	_	_
15	26-137	26-137	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	which	which	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	experimentally	experimentally	_	_	_	_	_	_	_
21	exchangeable	exchangeable	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	heterologous	heterologous	_	_	_	_	_	_	_
25	viral	viral	_	_	_	_	_	_	_
26	transcription-activating	transcription-activating	_	_	_	_	_	_	_
27	domain	domain	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	specificity	specificity	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	CIITA	CIITA	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	three	three	_	_	_	_	_	_	_
7	major	major	_	_	_	_	_	_	_
8	MHC	MHC	_	_	_	_	_	_	_
9	class	class	_	_	_	_	_	_	_
10	II	ii	_	_	_	_	_	_	_
11	genes	gene	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	DR	DR	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	DQ	DQ	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	DP	DP	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	is	be	_	_	_	_	_	_	_
20	mediated	mediate	_	_	_	_	_	_	_
21	by	by	_	_	_	_	_	_	_
22	its	its	_	_	_	_	_	_	_
23	remaining	remain	_	_	_	_	_	_	_
24	C-terminal	c-terminal	_	_	_	_	_	_	_
25	residues	residue	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	amino	amino	_	_	_	_	_	_	_
28	acids	acid	_	_	_	_	_	_	_
29	317-1130	317-1130	_	_	_	_	_	_	_
30	)	)	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	transactivation	transactivation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	multiple	multiple	_	_	_	_	_	_	_
5	cis	cis	_	_	_	_	_	_	_
6	elements	element	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	especially	especially	_	_	_	_	_	_	_
9	S	S	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	X2	X2	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	the	the	_	_	_	_	_	_	_
15	DR	DR	_	_	_	_	_	_	_
16	alpha	alpha	_	_	_	_	_	_	_
17	proximal	proximal	_	_	_	_	_	_	_
18	promoter	promoter	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	group	group	_	_	_	_	_	_	_
21	II	ii	_	_	_	_	_	_	_
22	CID	CID	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	is	be	_	_	_	_	_	_	_
25	CIITA	CIITA	_	_	_	_	_	_	_
26	dependent	dependent	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	CIITA	CIITA	_	_	_	_	_	_	_
3	overexpression	overexpression	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	normal	normal	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	did	do	_	_	_	_	_	_	_
8	not	not	_	_	_	_	_	_	_
9	increase	increase	_	_	_	_	_	_	_
10	class	class	_	_	_	_	_	_	_
11	II	ii	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	we	we	_	_	_	_	_	_	_
15	propose	propose	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	initiation	initiation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	CIITA	CIITA	_	_	_	_	_	_	_
20	expression	expression	_	_	_	_	_	_	_
21	serves	serve	_	_	_	_	_	_	_
22	as	as	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	on-off	on-off	_	_	_	_	_	_	_
25	switch	switch	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	while	while	_	_	_	_	_	_	_
28	availability	availability	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	downstream	downstream	_	_	_	_	_	_	_
31	interactor(s)	interactor(s)	_	_	_	_	_	_	_
32	limits	limit	_	_	_	_	_	_	_
33	transcription	transcription	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

